Get Data

Data Source

Controlled Substance Usage

Rhode Island Numbers

  • In October 2014 - Hydrocodone containing products moved from Schedule III to Schedule II.
  • While the number of prescriptions for stimulants continues to rise, there is a downward trend in the number of prescriptions for pain at the beginning of 2014.

  • The vast majority of prescribers are not using the Prescription Monitoring Program when they prescribe Schedule 2 drugs to check and see if the patient has other prescriptions.
  • While there is much opportunity for improvement, utilization of PMP reached its highest level in July 2015.
  • The recommended best practice is for providers to check the Prescription Monitoring Program before every Schedule 2 prescription is written.

  • Rhode Island ranks 4th in the US for benzodiazepine use per capita.

    • The number of individuals who were dispensed Schedule 2,3 drugs from more than 4 prescribers and more than 4 phamacies in a year doubled from 2004 to 2013. While the numbers have dropped a bit from 2011 there are still close to 1000 people a year who exhibit this abusive behavior.
    • We believe that increased utilization of the Prescription Monitoring Program by doctors and pharmacists will sharpen the downward trend.

    • Buprenorphine is used as part of Medication-Assisted Treatment (MAT) for patients who suffer from the chronic disease of addiction or opioid dependence.
    • The doses of the buprenorphine dispensed, used as part of Medication-Assisted Treatment (MAT) for patients who suffer from the chronic disease of addiction or those with opioid dependence has increased since January 2013.